This content is in French.
Testicular cancer: Does the future remain fertile?
26 novembre 2025
By Ana Espino | Published on November 26, 2025 | 3 min readTesticular cancer is the most common solid tumor in young men and carries an excellent prognosis thanks to current treatments such as surgery, chemotherapy, and radiotherapy. However, fertility preservation remains a major concern, as these treatments can impair spermatogenesis, either temporarily or permanently. This study was initiated t
By Ana Espino | Published on November 26, 2025 | 3 min read
Testicular cancer is the most common solid tumor in young men and carries an excellent prognosis thanks to current treatments such as surgery, chemotherapy, and radiotherapy. However, fertility preservation remains a major concern, as these treatments can impair spermatogenesis, either temporarily or permanently.
This study was initiated to evaluate the impact of anticancer treatments on the fertility of patients with testicular cancer, by analyzing the likelihood of natural conception and the birth of a live child after treatment, according to the different therapeutic regimens received.
Testicular cancer is the most common solid tumor in young men and carries an excellent prognosis thanks to current treatments such as surgery, chemotherapy, and radiotherapy. However, fertility preservation remains a major concern, as these treatments can impair spermatogenesis, either temporarily or permanently.
This study was initiated to evaluate the impact of anticancer treatments on the fertility of patients with testicular cancer, by analyzing the likelihood of natural conception and the birth of a live child after treatment, according to the different therapeutic regimens received.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Pape, J., et al. (2025). Oncological treatments have limited effects on the fertility prognosis in testicular cancer: A systematic review and meta‐analysis. Andrology, 13(4), 731-746
View the source
